Thirty-two lobbying groups representing the pharmaceutical industry spent more than $2 million in 2022, Politico reported Jan. 24.
Pharmaceutical Research and Manufacturers of America, more commonly known as PhRMA, spent more than double than the second-highest lobby. Most groups increased their spending efforts, and biotech Illumina nearly doubled its figure from $3.3 million to $6.1 million.
Here are the top 15, according to Politico:
|
Rank |
Organization |
2022 spending |
2021 spending |
|
1 |
Pharmaceutical Research and Manufacturers of America |
$28.3 million |
$29.6 million |
|
2 |
Pfizer |
$13.6 million |
$10.3 million |
|
3 |
Biotechnology Innovation Organization |
$13.3 million |
$13.3 million |
|
4 |
CVS Health |
$10.6 million |
$9.7 million |
|
5 |
Amgen |
$10.1 million |
$9.8 million |
|
6 |
Genentech |
$8.8 million |
$9.1 million |
|
7 |
Pharmaceutical Care Management Association |
$8.7 million |
$7.8 million |
|
8 |
Merck |
$8.3 million |
$8 million |
|
9 |
AbbVie |
$8.2 million |
$7 million |
|
10 |
Gilead Sciences |
$8 million |
$8.2 million |
|
11 |
Johnson & Johnson |
$7.8 million |
$6.1 million |
|
12 |
Eli Lilly |
$6.8 million |
$7 million |
|
13 |
Illumina |
$6.1 million |
$3.3 million |
|
14 |
Bayer |
$6 million |
$4.7 million |
|
15 |
Bristol Myers Squibb |
$5.4 million |
$5.4 million |